联邦医疗保险按服务付费中的修饰符22使用情况
该横断面分析纳入2021年联邦医疗保险按服务付费的625316例常见手术,评估修饰符22的使用率及其与报销的关联。不同手术的修饰符22编码比例为2.3%至8.5%,申报费用提高11.1%至22.8%,但被拒率更高(7.4% vs 4.0%,P < .001),总体平均支付结果不一。作者认为修饰符22几乎没有经济获益。
要点
- 不同手术的修饰符22使用率为2.3%至8.5%。
- 附修饰符22的申报费用提高11.1%至22.8%,但被拒率更高(7.4% vs 4.0%,P < .001)。
- 总体平均支付结果不一:4种手术降低、4种升高、2种无差异。
核心结论
- 作者认为,在多种手术中附加修饰符22几乎没有经济获益;在当前体系下,外科医生几乎没有理由申请修饰符22,且目前没有机制让外科医生为困难手术获得额外补偿。
研究设计与样本
- 横断面分析,使用2021年医师/供应商程序汇总有限数据集,纳入所有B部分承运商和耐用医疗设备按服务付费索赔。
- 评估10种常见手术的索赔,包括乳房切除术、全髋关节置换术、全膝关节置换术、冠状动脉旁路移植术、腹腔镜右半结肠切除术、腹腔镜阑尾切除术、腹腔镜胆囊切除术、肾移植、腹腔镜全子宫及双侧附件切除术和腰椎板切除术。
- 样本共纳入2021日历年实施的625316例手术;数据分析时间为2023年8月至11月。
主要发现
- 各手术的修饰符22编码比例从全膝关节置换术的5725/251521(2.3%)到腹腔镜全子宫及双侧附件切除术的1566/18459(8.5%)不等。
- 附修饰符22的申报费用提高11.1%(95%CI,9.1-13.2)至22.8%(95%CI,21.3-24.3),具体取决于手术。
- 在已接受的索赔中,附修饰符22的支付增加0.8%(95%CI,0.7-1.0)至4.8%(95%CI,4.5-5.1)。
- 附修饰符22的索赔更可能被拒(7.4% vs 4.0%;P < .001)。
- 总体平均支付结果不一:4种手术附修饰符22时支付降低,4种手术支付升高,2种手术无差异;肾移植附修饰符22的平均支付增加最多,为71.46美元(95%CI,55.32-87.60),相对增加3.4%(95%CI,2.9-4.6)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Modifier 22 is a mechanism designed for surgeons to identify cases that are more complex than their Current Procedural Terminology code accounts for. However, empirical studies of the use and efficacy of modifier 22 are lacking. OBJECTIVE: To assess the use of modifier 22 in common surgical procedures and the association of use with compensation. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional analysis of the 2021 Physician/Supplier Procedure Summary Limited Data Set including all Part B carrier and durable medical equipment fee-for-service claims. Claims for 10 common surgical procedures were evaluated, including mastectomy, total hip arthroplasty, total knee arthroplasty, coronary artery bypass grafting, laparoscopic right colectomy, laparoscopic appendectomy, laparoscopic cholecystectomy, kidney transplant, laparoscopic total abdominal hysterectomy and bilateral salpingo-oophorectomy, and lumbar laminectomy. Data were analyzed from August to November 2023. MAIN OUTCOMES AND MEASURES: Rate of modifier 22 use, rate of claim denial, mean charges, mean payment for accepted claims, and mean payment for all claims. RESULTS: The sample included 625 316 surgical procedures performed in calendar year 2021. The proportion of modifier 22 coding for a procedure ranged from 5725 of 251 521 (2.3%) in total knee arthroplasty to 1566 of 18 459 (8.5%) in laparoscopic total abdominal hysterectomy and bilateral salpingo-oophorectomy. Submitted charges were 11.1% (95% CI, 9.1-13.2) to 22.8% (95% CI, 21.3-24.3) higher for claims with modifier 22, depending on the procedure. Among accepted claims, those with modifier 22 had increased payments ranging from 0.8% (95% CI, 0.7-1.0) to 4.8% (95% CI, 4.5-5.1). However, claims with modifier 22 were more likely to be denied (7.4% vs 4.0%; P < .001). As a result, overall mean payments were mixed, with 4 procedures having lower payments when modifier 22 was appended, 4 procedures having higher payments with modifier 22, and 2 procedures with no difference. The largest increase in mean payment for modifier 22 claims was for kidney transplant with an increased payment of $71.46 (95% CI, 55.32-87.60), which translates to a relative increase of 3.4% (95% CI, 2.9-4.6). CONCLUSIONS AND RELEVANCE: The findings in this study suggest that modifier 22 had little to no financial benefit when appended to claims for a diverse panel of surgical procedures. In the current system, surgeons have little reason to request modifier 22, and no mechanisms currently exist for surgeons to recoup payment for difficult operations.
引用
- Childers CP, Manisundaram NV, Hu CY, et al. Modifier 22 Use in Fee-for-Service Medicare. JAMA Surg. 2024. PMID: 38506853. doi:10.1001/jamasurg.2024.0048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。